HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Maassen, J. A. Articles by Lemkes, H. H.P.J. Search for Related Content PubMed PubMed Citation Articles by Maassen, J. A. Articles by Lemkes, H. H.P.J. Social Bookmarking                What's this?

Mitochondrial Diabetes

Molecular Mechanisms and Clinical Presentation

¹ Department of Molecular Cell Biology, Leiden University Medical Centre, Leiden, the Netherlands
² Institute for Research in Extramural Medicine and Department of Endocrinology, Vrije Universiteit Medical Center, Amsterdam, the Netherlands
³ Department of Endocrinology and Metabolic Diseases, Leiden University Medical Centre, Leiden, the Netherlands

Mutations in mitochondrial DNA (mtDNA) associate with various disease states. A few mtDNA mutations strongly associate with diabetes, with the most common mutation being the A3243G mutation in the mitochondrial DNA-encoded tRNA(Leu,UUR) gene. This article describes clinical characteristics of mitochondrial diabetes and its molecular diagnosis. Furthermore, it outlines recent developments in the pathophysiological and molecular mechanisms leading to a diabetic state. A gradual development of pancreatic ß-cell dysfunction upon aging, rather than insulin resistance, is the main mechanism in developing glucose intolerance. Carriers of the A3243G mutation show during a hyperglycemic clamp at 10 mmol/l glucose a marked reduction in first- and second-phase insulin secretion compared with noncarriers. The molecular mechanism by which the A3243G mutation affects insulin secretion may involve an attenuation of cytosolic ADP/ATP levels leading to a resetting of the glucose sensor in the pancreatic ß-cell, such as in maturity-onset diabetes of the young (MODY)-2 patients with mutations in glucokinase. Unlike in MODY2, which is a nonprogressive form of diabetes, mitochondrial diabetes does show a pronounced age-dependent deterioration of pancreatic function indicating involvement of additional processes. Furthermore, one would expect that all mtDNA mutations that affect ATP synthesis lead to diabetes. This is in contrast to clinical observations. The origin of the age-dependent deterioration of pancreatic function in carriers of the A3243G mutation and the contribution of ATP and other mitochondrion-derived factors such as reactive oxygen species to the development of diabetes is discussed.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. E. Bainbridge, H. J. Hoffman, and C. C. Cowie Diabetes and Hearing Impairment in the United States: Audiometric Evidence from the National Health and Nutrition Examination Survey, 1999 to 2004 Ann Intern Med, July 1, 2008; 149(1): 1 - 10. [Abstract] [Full Text] [PDF]

				P. B. Bokko, L. Francione, E. Bandala-Sanchez, A. U. Ahmed, S. J. Annesley, X. Huang, T. Khurana, A. R. Kimmel, and P. R. Fisher Diverse Cytopathologies in Mitochondrial Disease Are Caused by AMP-activated Protein Kinase Signaling Mol. Biol. Cell, May 1, 2007; 18(5): 1874 - 1886. [Abstract] [Full Text] [PDF]

				D. B. Savage, K. F. Petersen, and G. I. Shulman Disordered Lipid Metabolism and the Pathogenesis of Insulin Resistance Physiol Rev, April 1, 2007; 87(2): 507 - 520. [Abstract] [Full Text] [PDF]

				T.-K. LIN, S.-D. CHEN, P.-W. WANG, Y.-H. WEI, C.-F. LEE, T.-L. CHEN, Y.-C. CHUANG, T.-Y. TAN, K.-C. CHANG, and C.-W. LIOU Increased Oxidative Damage with Altered Antioxidative Status in Type 2 Diabetic Patients Harboring the 16189 T to C Variant of Mitochondrial DNA Ann. N.Y. Acad. Sci., May 1, 2005; 1042(1): 64 - 69. [Abstract] [Full Text] [PDF]

				B. B. Lowell and G. I. Shulman Mitochondrial Dysfunction and Type 2 Diabetes Science, January 21, 2005; 307(5708): 384 - 387. [Abstract] [Full Text] [PDF]